Prot#101-09: APhase 2 Study to Assess the Efficacy and Safety of CAL-101 in Patients with Indolent B-Cell Non-Hodgkin Lymphoma Refractory to Rituximab and Alkylating Agents

Project: Research project

Project Details

StatusFinished
Effective start/end date2/20/122/10/18

Funding

  • INC Research, LLC (PRESPEND)
  • Gilead Calistoga, LLC (PRESPEND)